Year archive

SYNTARA LIMITED — 2006 filings

All 82 regulatory filings released by SYNTARA LIMITED (SNT) in 2006, sourced directly from the official regulator.

82 Filings

2006 Period

2006 filings (82)

Filing	Released	Lang
Appendix 3B 10 pages ?Kb Regulatory Filings	2006-12-17	English
Appendix 3B - Exercise of Employee Options 9 pages ?Kb Regulatory Filings	2006-12-14	English
Appoints Dutch Distributor for Aridol 2 pages ?Kb Regulatory Filings	2006-12-13	English
2006 Form 20-F filed with US SEC 131 pages ?Kb Regulatory Filings	2006-12-06	English
Appendix 3B 9 pages ?Kb Regulatory Filings	2006-12-06	English
Ceasing to be a substantial holder 1 page ?Kb Regulatory Filings	2006-11-30	English
Change in substantial holding 6 pages ?Kb Regulatory Filings	2006-11-30	English
Appendix 3B Exercise of employee options 9 pages ?Kb Capital/Financing Update	2006-11-26	English
US Fast-Tracks Pharmaxis Cystic Fibrosis Drug 2 pages ?Kb Regulatory Filings	2006-11-21	English
Phase III Results for Aridol 3 pages ?Kb Regulatory Filings	2006-11-15	English
Media Rel: Aridol Endorsed in Global & Australian Guidelines 2 pages ?Kb Regulatory Filings	2006-11-15	English
New Board Director 1 page ?Kb Regulatory Filings	2006-11-14	English
Initial Director's Interest Notice 2 pages ?Kb Regulatory Filings	2006-11-14	English
Proposed Grant of Options 1 page ?Kb Share Issue/Capital Change	2006-11-14	English
Change in substantial holding 6 pages ?Kb Major Shareholding Notification	2006-11-07	English
Change in substantial holding 4 pages ?Kb Major Shareholding Notification	2006-11-06	English
Appendix 3B 9 pages ?Kb Share Issue/Capital Change	2006-11-05	English
Quarterly Report to Shareholders 8 pages ?Kb Interim / Quarterly Report	2006-11-02	English
Commitments Test Entity - First Quarter Report 5 pages ?Kb Interim / Quarterly Report	2006-10-30	English
Results of Meeting 5 pages ?Kb Declaration of Voting Results & Voting Rights Announcements	2006-10-26	English
Appendix 3B 10 pages ?Kb Capital/Financing Update	2006-10-26	English
Final Director's Interest Notice 2 pages ?Kb Regulatory Filings	2006-10-26	English
Change of Director's Interest Notice x5 10 pages ?Kb Director's Dealing	2006-10-26	English
CEO Presentation to AGM 24 pages ?Kb Annual Report	2006-10-25	English
Chairman's Address to Shareholders 2 pages ?Kb AGM Information	2006-10-25	English
Aridol gains Swedish Approval 2 pages ?Kb Regulatory Filings	2006-10-24	English
Appoints Aridol Distributor for Italy 2 pages ?Kb Capital/Financing Update	2006-10-18	English
Appendix 3B 9 pages ?Kb Share Issue/Capital Change	2006-10-18	English
Updated Investor Presentation 30 pages ?Kb Investor Presentation	2006-10-11	English
UK Approval for Phase III Cystic Fibrosis Trial 3 pages ?Kb Regulatory Filings	2006-10-05	English
Change of Director's Interest Notice 2 pages ?Kb Regulatory Filings	2006-10-02	English
Appoints Aridol Distributor for Greece 2 pages ?Kb Regulatory Filings	2006-10-02	English
Notice of Annual General Meeting 2006 15 pages ?Kb AGM Information	2006-09-24	English
2006 Annual Report 108 pages ?Kb Regulatory Filings	2006-09-24	English
2006 Annual Report 108 pages ?Kb Annual Report	2006-09-24	English
Board Change 2 pages ?Kb Board/Management Information	2006-09-21	English
Appendix 3B - Issue of Employee Options 9 pages ?Kb Capital/Financing Update	2006-09-19	English
Appendix 3B 10 pages ?Kb Capital/Financing Update	2006-09-03	English
US Phase III Aridol Trial closed 2 pages ?Kb Regulatory Filings	2006-08-27	English
Proposed Issue of Employee Options 2 pages ?Kb Regulatory Filings	2006-08-14	English
Appendix 3B - Issue of Employee Options 10 pages ?Kb Capital/Financing Update	2006-08-14	English
Quarterly Report to Shareholders 8 pages ?Kb Interim / Quarterly Report	2006-08-07	English
Preliminary Final Report 41 pages ?Kb Annual Report	2006-08-07	English
Investor Conference Call 1 page ?Kb Report Publication Announcement	2006-08-03	English
Commitments Test Entity - Fourth Quarter Report 5 pages ?Kb Interim / Quarterly Report	2006-07-30	English
Files Aridol Marketing Application in Switzerland 2 pages ?Kb Regulatory Filings	2006-07-20	English
Appendix 3B 9 pages ?Kb Share Issue/Capital Change	2006-07-18	English
Updated Investor Presentation 27 pages ?Kb Investor Presentation	2006-07-06	English
First commercial supply of Aridol to US Market 2 pages ?Kb Capital/Financing Update	2006-06-29	English
Appendix 3B-Employee Options 9 pages ?Kb Regulatory Filings	2006-06-05	English
Appendix 3B 9 pages ?Kb Capital/Financing Update	2006-06-05	English
Change of Director's Interest Notice 2 pages ?Kb Director's Dealing	2006-05-07	English
Appendix 3B 9 pages ?Kb Capital/Financing Update	2006-05-04	English
Bronchitol Proceeding to Phase III Trials in Cystic Fibrosis 2 pages ?Kb Capital/Financing Update	2006-05-01	English
Commitments Test Entity - Third Quarter Report 8 pages ?Kb Interim / Quarterly Report	2006-04-27	English
Commitments Test Entity - Third Quarter Report 5 pages ?Kb Interim / Quarterly Report	2006-04-27	English
Enrols first patient in Phase III Bronchiectasis Trial 3 pages ?Kb Regulatory Filings	2006-04-18	English
Pharmaxis Board Change 1 page ?Kb Board/Management Information	2006-04-10	English
Final Director's Interest Notice 2 pages ?Kb Director's Dealing	2006-04-10	English
Completes Enrolment in Aridol COPD Trial 3 pages ?Kb Regulatory Filings	2006-04-10	English
Pharmaxis Secures Licence for Dry Powder Manufacture 2 pages ?Kb Regulatory Filings	2006-04-06	English
Proposed Issue of Options 1 page ?Kb Share Issue/Capital Change	2006-03-26	English
Aridol approved by TGA 2 pages ?Kb Regulatory Filings	2006-03-22	English
Updated Investor Presentation 33 pages ?Kb Investor Presentation	2006-03-20	English
Final Director's Interest Notice 2 pages ?Kb Director's Dealing	2006-03-20	English
Initial Director's Interest Notice 2 pages ?Kb Director's Dealing	2006-03-20	English
Majority of Pharmaxis Board Now Independent 2 pages ?Kb Board/Management Information	2006-03-19	English
Director Appointment 2 pages ?Kb Board/Management Information	2006-03-15	English
Pharmaxis Admitted to S&P ASX 300 and All Ordinaries 1 Regulatory Filings	2006-03-02	English
Appendix 3B 9 pages ?Kb Capital/Financing Update	2006-02-19	English
Aridol recommended for Market Authorisation by ADEC 2 pages ?Kb Regulatory Filings	2006-02-12	English
Appendix 3B 9 pages ?Kb Share Issue/Capital Change	2006-02-09	English
Half Yearly Report & Half Year Accounts 30 pages ?Kb Interim / Quarterly Report	2006-02-09	English
Quarterly Report to Shareholders 8 pages ?Kb Interim / Quarterly Report	2006-02-09	English
Investor Presentation 33 pages ?Kb Investor Presentation	2006-02-09	English
Signs Swiss Marketing Partner for Aridol 3 pages ?Kb Capital/Financing Update	2006-02-05	English
Commences Operations in Europe 3 pages ?Kb Board/Management Information	2006-02-05	English
Change of Director's Interest Notice 2 pages ?Kb Director's Dealing	2006-01-31	English
Commitments Test Entity - Second Quarter Report 5 pages ?Kb Interim / Quarterly Report	2006-01-30	English
Appendix 3B - Exercise of Employee Options 9 pages ?Kb Capital/Financing Update	2006-01-30	English
Release from voluntary escrow 1 page ?Kb Regulatory Filings	2006-01-19	English
Signs first distributor for Aridol 3 pages ?Kb Regulatory Filings	2006-01-17	English

Filings by year

2026 36 filings
2025 88 filings
2024 101 filings
2023 72 filings
2022 95 filings
2021 96 filings
2020 65 filings
2019 48 filings
2018 69 filings
2017 53 filings
2016 43 filings
2015 58 filings
2014 33 filings
2013 70 filings
2012 71 filings
2011 90 filings
2010 77 filings
2009 74 filings
2008 67 filings
2007 85 filings
2006 82 filings
2005 79 filings
2004 55 filings
2003 11 filings